Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (311-320 of 688) with videos related to

Pageof 69
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2025
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc AnalysisPeter Rossing, Andreas L Birkenfeld, Paola Fioretto, et al.
European Heart Journal|June 22, 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trialNicolas Girerd, Tim Collier, Stuart Pocock, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample populationAdrienne-Denise V Bilbao, Jennifer Goldschmied, Angela Jang, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
Nature Medicine|February 3, 2007
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityJane A Leopold, Aamir Dam, Bradley A Maron, et al.
The New England Journal of Medicine|November 16, 2010
Eplerenone in patients with systolic heart failure and mild symptomsFaiez Zannad, John J V McMurray, Henry Krum, et al.
American Heart Journal|April 30, 2013
Current medical management of stable coronary artery disease before and after elective percutaneous coronary interventionAmer K Ardati, Bertram Pitt, Dean E Smith, et al.
Circulation. Heart Failure|October 8, 2009
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failureJohn J V McMurray, Bertram Pitt, Roberto Latini, et al.
The American Journal of Cardiology|August 19, 2015
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical TrialsSakima A Smith, Robert J Mentz, Lothar Roessig, et al.
Pharmacoeconomics|May 16, 2019
Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with HyperkalemiaMark Bounthavong, Javed Butler, Chantal M Dolan, et al.
Pageof 69

Showing results (311-320 of 688) with videos related to

Sort By:
Pageof 69
Clinical Journal of the American Society of Nephrology : CJASN|May 2, 2025
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc AnalysisPeter Rossing, Andreas L Birkenfeld, Paola Fioretto, et al.
European Heart Journal|June 22, 2015
Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trialNicolas Girerd, Tim Collier, Stuart Pocock, et al.
International Journal of Cardiology. Heart & Vasculature|July 14, 2021
A preliminary study on the relationship between sleep, depression and cardiovascular dysfunction in a 4 sample populationAdrienne-Denise V Bilbao, Jennifer Goldschmied, Angela Jang, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
Nature Medicine|February 3, 2007
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activityJane A Leopold, Aamir Dam, Bradley A Maron, et al.
The New England Journal of Medicine|November 16, 2010
Eplerenone in patients with systolic heart failure and mild symptomsFaiez Zannad, John J V McMurray, Henry Krum, et al.
American Heart Journal|April 30, 2013
Current medical management of stable coronary artery disease before and after elective percutaneous coronary interventionAmer K Ardati, Bertram Pitt, Dean E Smith, et al.
Circulation. Heart Failure|October 8, 2009
Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failureJohn J V McMurray, Bertram Pitt, Roberto Latini, et al.
The American Journal of Cardiology|August 19, 2015
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical TrialsSakima A Smith, Robert J Mentz, Lothar Roessig, et al.
Pharmacoeconomics|May 16, 2019
Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with HyperkalemiaMark Bounthavong, Javed Butler, Chantal M Dolan, et al.
Pageof 69